Valuation BioHarvest Sciences Inc. Canadian Securities Exchange
Stocks
BHSC
CA13767B1013
Pharmaceuticals
|
Delayed
Canadian Securities Exchange
07:54:58 05/10/2021 pm IST
|
5-day change | 1st Jan Change | ||
| 0.3500 CAD | +6.06% |
|
-2.94% | +46.67% |
| 02/10 | BioHarvest Sciences Inc. announces an Equity Buyback for 1,133,392 shares, representing 5% of its issued share capital. | CI |
| 29/09 | BioHarvest Sciences Inc. authorizes a Buyback Plan. | CI |
Company Valuation: BioHarvest Sciences Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 75.75 | 107.1 | 117.6 | 33.78 | - | - |
| Change | - | 41.36% | 9.8% | -71.27% | - | - |
| Enterprise Value (EV) | 75.75 | 107.1 | 117.6 | 33.78 | 33.78 | 33.78 |
| Change | - | 41.36% | 9.8% | -71.27% | 0% | 0% |
| P/E | -5.28x | -7.73x | -8.65x | -2.82x | -4.45x | 11.5x |
| PBR | - | - | - | - | - | - |
| PEG | - | 0.3x | 0.3x | 0.2x | 0.1x | -0x |
| Capitalization / Revenue | - | 4.25x | 3.41x | 0.9x | 0.68x | 0.47x |
| EV / Revenue | - | 0x | 0x | 0.9x | 0.68x | 0.47x |
| EV / EBITDA | - | -0x | -0x | -4.43x | -9.28x | 7.06x |
| EV / EBIT | - | -0x | -0x | -3.76x | -6.94x | 6.08x |
| EV / FCF | - | -0x | -0x | -2.86x | -2.56x | 7.89x |
| FCF Yield | - | -8.89% | -8.15% | -34.9% | -39% | 12.7% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.05 | -0.8 | -0.6 | -0.5275 | -0.335 | 0.13 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | 25.19 | 34.51 | 37.42 | 49.59 | 71.53 |
| EBITDA 1 | - | -5.738 | -3.951 | -7.618 | -3.641 | 4.786 |
| EBIT 1 | - | -6.989 | -5.575 | -8.977 | -4.87 | 5.555 |
| Net income 1 | -12.56 | -12.91 | -11.14 | -12.02 | -7.648 | 3.409 |
| Net Debt | - | - | - | - | - | - |
| Reference price 2 | 5.539 | 6.180 | 5.190 | 1.490 | 1.490 | 1.490 |
| Nbr of stocks (in thousands) | 13,677 | 17,328 | 22,654 | 22,668 | - | - |
| Announcement Date | 30/04/24 | 31/03/25 | 31/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 33.76x | 12.26x | 24.76x | 0.58% | 1,06000Cr | |
| 28.75x | 6.35x | 18.21x | 2.07% | 62TCr | |
| 34.38x | 7.99x | 16.52x | 2.56% | 48TCr | |
| 103.88x | 5.82x | 24.82x | 2.39% | 35TCr | |
| 19.43x | 4.75x | 11.8x | 2.78% | 35TCr | |
| 20.28x | 5.28x | 13.08x | 3.01% | 27TCr | |
| 20.79x | 4.27x | 12.2x | 2.08% | 25TCr | |
| 26.09x | 6.8x | 12.11x | 2.44% | 22TCr | |
| -44.42x | 6.54x | 25.48x | 2.24% | 18TCr | |
| Average | 26.99x | 6.67x | 17.66x | 2.24% | 42.09TCr | |
| Weighted average by Cap. | 32.19x | 7.84x | 19.08x | 1.91% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BHST Stock
- BHSC Stock
- Valuation BioHarvest Sciences Inc.
Select your edition
All financial news and data tailored to specific country editions
